Keenova Therapeutics plc Financial and Nonfinancial Liabilities, Fair Value Disclosure
Keenova Therapeutics plc had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $73.40 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-08-11
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $73.40M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $75.20M.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $76.50M.
- 2024-12-27: Financial and Nonfinancial Liabilities, Fair Value Disclosure $30.10M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $73.40M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $75.20M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $76.50M 10-Q · filed 2026-08-11 |
| 2024-12-27 | $30.10M 10-K · filed 2026-04-15 |